The HIV treatment cascade and antiretroviral impact in different populations

Current Opinion in HIV and AIDS

Volumn 10, Issue 6, 2015, Pages 391-394

  Bärnighausen, Till ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

ANTIVIRAL THERAPY; COST EFFECTIVENESS ANALYSIS; CULTURAL COMPETENCE; DECENTRALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIGRANT; NONHUMAN; POSTNATAL CARE; PRENATAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; DISEASE TRANSMISSION; HEALTH CARE DELIVERY; HEALTH SERVICES RESEARCH; HIV INFECTIONS; POPULATION GROUP; PREVENTION AND CONTROL; PROCEDURES; TREATMENT OUTCOME;

ANTI-RETROVIRAL AGENTS; DELIVERY OF HEALTH CARE; DISEASE TRANSMISSION, INFECTIOUS; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; POPULATION GROUPS; TREATMENT OUTCOME;

EID: 84943772165     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000205     Document Type: Review

References (21)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med 1998; 338:853-860.
2. Mills EJ, Bakanda C, Birungi J, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from uganda. Ann Intern Med 2011; 155:209-216.
3. Nieuwkerk PT, Gisolf EH, Reijers MH, et al. Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS 2001; 15:1985-1991.
4. Jaquet A, Garanet F, Balestre E, et al. Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso. J Int AIDS Soc 2013; 16:18867.
5. Bor J, Tanser F, Newell ML, Bärnighausen T. In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment. Health Aff (Millwood) 2012; 31:1459-1469.
6. Rosen S, Larson B, Rohr J, et al. Effect of antiretroviral therapy on patients' economic well being: five-year follow-up. AIDS 2014; 28:417-424.
7. Montaner JS, Wood E, Kerr T, et al. Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes. J Acquir Immune Defic Syndr 2010; 55 (Suppl 1): S5-S9.
8. Tanser F, Bärnighausen T, Grapsa E, et al. High coverage of art associated with decline in risk of HIV acquisition in rural Kwazulu-Natal, South Africa. Science 2013; 339:966-971.
9. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
10. Havlir D, Beyrer C. The beginning of the end of aids? N Engl J Med 2012; 367:685-687.
11. Granich R, Williams B, Montaner J. Fifteen million people on antiretroviral treatment by 2015: treatment as prevention. Curr Opin HIV AIDS 2013; 8:41-49.
12. El-Sadr WM, Gamble TR, Cohen MS. Linkage from HIV testing to care: a positive test often leads nowhere. Sexually Transmit Dis 2013; 40:26-27.
13. Plazy M, Orne-Gliemann J, Dabis F, Dray-Spira R. Retention in care prior to antiretroviral treatment eligibility in sub-Saharan Africa: a systematic review of the literature. BMJ Open 2015; 5:e006927.
14. Fox MP, Rosen S. Retention of adult patients on antiretroviral therapy in low-and middle-income countries: systematic review and meta-analysis 2008-2013. J Acquir Immune Defic Syndr 2015; 69:98-108.
15. Govindasamy D, Kranzer K, Ford N. Strengthening the HIV cascade to ensure an effective future art response in sub-Saharan Africa. Trans Royal Soc Trop Med Hyg 2014; 108:1-3.
16. UNAIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. UNAIDS: Geneva, Switzerland; 2014.
17. Tanser F, de Oliveira T, Maheu-Giroux M, Bärnighausen T. Concentrated HIV subepidemics in generalized epidemic settings. Curr Opin HIV AIDS 2014; 9:115-125.
18. Groves P, Kayyali B, Knott D, Van Kuiken S. The 'big data' revolution in healthcare: accelerating value and innovation. McKinsey & Company; 2013.
19. Ford N, Calmy A. Improving first-line antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS 2010; 5:38-47.
20. Vermund SH, Sidat M, Weil LF, et al. Transitioning HIV care and treatment programs in Southern Africa to full local management. AIDS 2012; 26:1303-1310.
21. Abrams EJ, El-Sadr WM. Lessons from Harlem: relevance to a global epidemic. J Acquir Immune Defic Syndr 2009; 52 (Suppl 1): S24-S26.